Literature DB >> 16075043

Genetics of acquired long QT syndrome.

Dan M Roden1, Prakash C Viswanathan.   

Abstract

The QT interval is the electrocardiographic manifestation of ventricular repolarization, is variable under physiologic conditions, and is measurably prolonged by many drugs. Rarely, however, individuals with normal base-line intervals may display exaggerated QT interval prolongation, and the potentially fatal polymorphic ventricular tachycardia torsade de pointes, with drugs or other environmental stressors such as heart block or heart failure. This review summarizes the molecular and cellular mechanisms underlying this acquired or drug-induced form of long QT syndrome, describes approaches to the analysis of a role for DNA variants in the mediation of individual susceptibility, and proposes that these concepts may be generalizable to common acquired arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16075043      PMCID: PMC1180553          DOI: 10.1172/JCI25539

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  92 in total

1.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 2.  Antiarrhythmic drug target choices and screening.

Authors:  Michael C Sanguinetti; Paul B Bennett
Journal:  Circ Res       Date:  2003-09-19       Impact factor: 17.367

Review 3.  Drug-induced prolongation of the QT interval.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

Review 4.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

Review 5.  Assessing predictors of drug-induced torsade de pointes.

Authors:  Luiz Belardinelli; Charles Antzelevitch; Marc A Vos
Journal:  Trends Pharmacol Sci       Date:  2003-12       Impact factor: 14.819

6.  Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome.

Authors:  Michael J Ackerman; David J Tester; Gregg S Jones; Melissa L Will; Christopher R Burrow; Mark E Curran
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

7.  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.

Authors:  Caroline S Fox; Helen Parise; Ralph B D'Agostino; Donald M Lloyd-Jones; Ramachandran S Vasan; Thomas J Wang; Daniel Levy; Philip A Wolf; Emelia J Benjamin
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

8.  Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure.

Authors:  Fadi G Akar; David S Rosenbaum
Journal:  Circ Res       Date:  2003-08-21       Impact factor: 17.367

9.  Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

Authors:  Aimée D C Paulussen; Ronaldus A H J Gilissen; Martin Armstrong; Pieter A Doevendans; Peter Verhasselt; Hubert J M Smeets; Eric Schulze-Bahr; Wilhelm Haverkamp; Günter Breithardt; Nadine Cohen; Jeroen Aerssens
Journal:  J Mol Med (Berl)       Date:  2004-02-04       Impact factor: 4.599

10.  Physicochemical features of the HERG channel drug binding site.

Authors:  David Fernandez; Azad Ghanta; Gregory W Kauffman; Michael C Sanguinetti
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

View more
  81 in total

1.  Coexisting mutations/polymorphisms of the long QT syndrome genes in patients with repaired Tetralogy of Fallot are associated with the risks of life-threatening events.

Authors:  Shuenn-Nan Chiu; Mei-Hwan Wu; Ming-Jai Su; Jou-Kou Wang; Ming-Tai Lin; Chien-Chih Chang; Hui-Wen Hsu; Ching-Tsuen Shen; Olivier Thériault; Mohamed Chahine
Journal:  Hum Genet       Date:  2012-03-11       Impact factor: 4.132

2.  The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes.

Authors:  Elijah R Behr; Craig January; Eric Schulze-Bahr; Andrew A Grace; Stefan Kääb; Monica Fiszman; Shaniece Gathers; Shaavhrée Buckman; Ashraf Youssef; Munir Pirmohamed; Dan Roden
Journal:  Eur Heart J       Date:  2012-07-02       Impact factor: 29.983

3.  [Perioperative monitoring of the QT interval].

Authors:  H Pfizenmayer; P Friederich
Journal:  Anaesthesist       Date:  2010-07       Impact factor: 1.041

Review 4.  Drug- and non-drug-associated QT interval prolongation.

Authors:  Charlotte van Noord; Mark Eijgelsheim; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

Review 5.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

6.  Genetic predisposition and cellular basis for ischemia-induced ST-segment changes and arrhythmias.

Authors:  Dan Hu; Sami Viskin; Antonio Oliva; Jonathan M Cordeiro; Alejandra Guerchicoff; Guido D Pollevick; Charles Antzelevitch
Journal:  J Electrocardiol       Date:  2007 Nov-Dec       Impact factor: 1.438

7.  Contribution of I Ks to ventricular repolarization in canine myocytes.

Authors:  Balázs Horváth; János Magyar; Norbert Szentandrássy; Péter Birinyi; Péter P Nánási; Tamás Bányász
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

8.  Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification.

Authors:  Elena Sommariva; Carlo Pappone; Filippo Martinelli Boneschi; Chiara Di Resta; Maria Rosaria Carbone; Erika Salvi; Pasquale Vergara; Simone Sala; Daniele Cusi; Maurizio Ferrari; Sara Benedetti
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

9.  Astemizole-based turn-on fluorescent probes for imaging hERG potassium channel.

Authors:  Xiaomeng Zhang; Tingting Liu; Beilei Wang; Yuqi Gao; Pan Liu; Minyong Li; Lupei Du
Journal:  Medchemcomm       Date:  2019-02-26       Impact factor: 3.597

Review 10.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.